124 related articles for article (PubMed ID: 38619967)
1. Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells.
Zhuang X; Woods J; Ji Y; Scheich S; Mo F; Rajagopalan S; Coulibaly ZA; Voss M; Urlaub H; Staudt LM; Pan KT; Long EO
Cell Rep; 2024 Apr; 43(4):114105. PubMed ID: 38619967
[TBL] [Abstract][Full Text] [Related]
2. Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.
Okamoto T; Yoneyama MS; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C; Tsuboi S
Mol Med Rep; 2013 Feb; 7(2):359-64. PubMed ID: 23165940
[TBL] [Abstract][Full Text] [Related]
3. Secretome analysis identifies novel signal Peptide peptidase-like 3 (Sppl3) substrates and reveals a role of Sppl3 in multiple Golgi glycosylation pathways.
Kuhn PH; Voss M; Haug-Kröper M; Schröder B; Schepers U; Bräse S; Haass C; Lichtenthaler SF; Fluhrer R
Mol Cell Proteomics; 2015 Jun; 14(6):1584-98. PubMed ID: 25827571
[TBL] [Abstract][Full Text] [Related]
4. Metabolic engineering challenges of extending N-glycan pathways in Chinese hamster ovary cells.
Wang Q; Wang T; Yang S; Sha S; Wu WW; Chen Y; Paul JT; Shen RF; Cipollo JF; Betenbaugh MJ
Metab Eng; 2020 Sep; 61():301-314. PubMed ID: 32663509
[TBL] [Abstract][Full Text] [Related]
5. NK Cell Maturation and Cytotoxicity Are Controlled by the Intramembrane Aspartyl Protease SPPL3.
Hamblet CE; Makowski SL; Tritapoe JM; Pomerantz JL
J Immunol; 2016 Mar; 196(6):2614-26. PubMed ID: 26851218
[TBL] [Abstract][Full Text] [Related]
6. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
Suzuki Y; Sutoh M; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Habuchi T; Arai Y; Fukuda M; Ohyama C; Tsuboi S
Int J Oncol; 2012 Jun; 40(6):1831-8. PubMed ID: 22446589
[TBL] [Abstract][Full Text] [Related]
7. A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.
Tsuboi S; Sutoh M; Hatakeyama S; Hiraoka N; Habuchi T; Horikawa Y; Hashimoto Y; Yoneyama T; Mori K; Koie T; Nakamura T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C
EMBO J; 2011 Jun; 30(15):3173-85. PubMed ID: 21712812
[TBL] [Abstract][Full Text] [Related]
8. Restricted processing of CD16a/Fc γ receptor IIIa
Patel KR; Roberts JT; Subedi GP; Barb AW
J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
[TBL] [Abstract][Full Text] [Related]
9. N-terminome analyses underscore the prevalence of SPPL3-mediated intramembrane proteolysis among Golgi-resident enzymes and its role in Golgi enzyme secretion.
Hobohm L; Koudelka T; Bahr FH; Truberg J; Kapell S; Schacht SS; Meisinger D; Mengel M; Jochimsen A; Hofmann A; Heintz L; Tholey A; Voss M
Cell Mol Life Sci; 2022 Mar; 79(3):185. PubMed ID: 35279766
[TBL] [Abstract][Full Text] [Related]
10. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
[TBL] [Abstract][Full Text] [Related]
11. Method for Identifying Galectin Ligands on Lymphocyte Membrane Glycoproteins.
Patel KR; Barb AW; Stowell SR
Methods Mol Biol; 2022; 2442():215-232. PubMed ID: 35320529
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human poly-N-acetyl-lactosamine synthase structure with GT-A fold glycosyltransferases supports a modular assembly of catalytic subsites.
Kadirvelraj R; Yang JY; Kim HW; Sanders JH; Moremen KW; Wood ZA
J Biol Chem; 2021; 296():100110. PubMed ID: 33229435
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells.
Capuano C; Romanelli M; Pighi C; Cimino G; Rago A; Molfetta R; Paolini R; Santoni A; Galandrini R
Cancer Res; 2015 Oct; 75(19):4097-108. PubMed ID: 26229120
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.
Wild J; Schmiedel BJ; Maurer A; Raab S; Prokop L; Stevanović S; Dörfel D; Schneider P; Salih HR
Leukemia; 2015 Aug; 29(8):1676-83. PubMed ID: 25710310
[TBL] [Abstract][Full Text] [Related]
15. A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.
Lee DH; Ahn H; Sim HI; Choi E; Choi S; Jo Y; Yun B; Song HK; Oh SJ; Denda-Nagai K; Park CS; Irimura T; Park Y; Jin HS
J Exp Clin Cancer Res; 2023 Oct; 42(1):272. PubMed ID: 37858248
[TBL] [Abstract][Full Text] [Related]
16. Non-Coated Rituximab Induces Highly Cytotoxic Natural Killer Cells From Peripheral Blood Mononuclear Cells
Niu C; Chen Y; Li M; Zhu S; Zhou L; Xu D; Li Z; Xu J; Li W; Wang Y; Cui J
Front Immunol; 2021; 12():658562. PubMed ID: 34113342
[TBL] [Abstract][Full Text] [Related]
17. Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis.
Mkhikian H; Mortales CL; Zhou RW; Khachikyan K; Wu G; Haslam SM; Kavarian P; Dell A; Demetriou M
Elife; 2016 Jun; 5():. PubMed ID: 27269286
[TBL] [Abstract][Full Text] [Related]
18. Shedding of glycan-modifying enzymes by signal peptide peptidase-like 3 (SPPL3) regulates cellular N-glycosylation.
Voss M; Künzel U; Higel F; Kuhn PH; Colombo A; Fukumori A; Haug-Kröper M; Klier B; Grammer G; Seidl A; Schröder B; Obst R; Steiner H; Lichtenthaler SF; Haass C; Fluhrer R
EMBO J; 2014 Dec; 33(24):2890-905. PubMed ID: 25354954
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans.
Peng W; Pranskevich J; Nycholat C; Gilbert M; Wakarchuk W; Paulson JC; Razi N
Glycobiology; 2012 Nov; 22(11):1453-64. PubMed ID: 22786570
[TBL] [Abstract][Full Text] [Related]
20. A functional mammalian display screen identifies rare antibodies that stimulate NK cell-mediated cytotoxicity.
Kang E; Kadoch C; Rubenstein JL; Lanier LL; Wells JA
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34330834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
